Search results

Jump to navigation Jump to search

Page title matches

  • ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b
    1 KB (165 words) - 10:54, 9 July 2009
  • 183 bytes (23 words) - 02:30, 12 February 2009
  • Auto-populated based on [[Special:WhatLinksHere/Protein kinase]]. Needs checking by a human.
    687 bytes (86 words) - 19:46, 11 January 2010

Page text matches

  • Auto-populated based on [[Special:WhatLinksHere/Protein kinase]]. Needs checking by a human.
    687 bytes (86 words) - 19:46, 11 January 2010
  • ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b
    1 KB (165 words) - 10:54, 9 July 2009
  • The serine/threonine protein kinase B (PKB) family or Akt is an important downstream signaling component of tyr
    304 bytes (43 words) - 02:10, 16 May 2009
  • {{r|Protein kinase}}
    641 bytes (79 words) - 16:44, 11 January 2010
  • {{r|Protein kinase}}
    576 bytes (72 words) - 16:44, 11 January 2010
  • {{r|Protein kinase inhibitor}}
    109 bytes (13 words) - 12:24, 31 May 2009
  • {{r|Protein kinase||**}}
    1 KB (156 words) - 08:01, 16 April 2010
  • ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s such as [[G-protein-coupled receptor kinase]] which then affect downstre
    5 KB (679 words) - 09:15, 29 August 2009
  • ...pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway."<ref>{{MeSH}} ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b
    2 KB (329 words) - 10:52, 9 July 2009
  • ...[[insulin]], and [[oxytocin]] and it has been found to activate specific [[protein kinase]]s."<ref>{{MeSH}}</ref> ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b
    1 KB (203 words) - 10:53, 9 July 2009
  • ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s such as [[G-protein-coupled receptor kinase]] which then affect downstre
    3 KB (338 words) - 13:08, 30 March 2010
  • 385 bytes (52 words) - 17:06, 14 May 2010
  • {{r|Protein kinase}}
    1 KB (147 words) - 07:44, 8 January 2010
  • ...tion of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase. ([[Medical Subject Headings]])
    482 bytes (77 words) - 11:57, 2 July 2009
  • ===[[Protein kinase]] inhibitors=== {{r|Protein kinase}}
    4 KB (467 words) - 00:17, 6 February 2009
  • ...se-[[cyclic AMP]] primarily and also [[cyclic GMP]] which then activates [[protein kinase]]s.
    1 KB (147 words) - 06:58, 14 September 2013
  • [[Genetic polymorphism]]s of the protein kinase associated with β-2 [[adrenergic receptor]]s may affect the response in [[
    6 KB (767 words) - 17:34, 10 February 2024
  • {{r|Protein kinase}}
    1 KB (148 words) - 16:21, 11 January 2010
  • ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b
    1 KB (197 words) - 10:52, 9 July 2009
  • ...um channels]] in the [[endoplasmic reticulum]] of various cell types and [[protein kinase]] C, respectively.
    6 KB (929 words) - 15:37, 12 November 2007
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)